Thursday, January 6, 2022

The Treatment Nihilism of our Government Continues Unabated

By Daniel Horowitz - January 06, 2022 at 12:52AM

undefined

The calls have become all too familiar. People who know that I’m friends with a bunch of top-notch doctors who actually treat COVID call up desperately searching for someone who will help. Last week, I got a call from a family member of a 47-year-old diabetic who suffers from epilepsy and hypertension who was in a Maryland hospital on BiPAP with a blood oxygen level of 83. This man kept away from people for two years and got three shots, but they failed him, and now he was getting nothing but the dangerous remdesivir. Oh, and the monoclonal antibodies are not available. This man now suffers the fate of hundreds of thousands of other people who are victims of therapeutic nihilism.

Just how much does the federal government want to choke off all forms of outpatient treatment for COVID, despite the evidence of so many affective therapeutics? As they make the monoclonal antibody treatments scarcer by the day, the NIH has now manipulated its own website to cover up its original position on ivermectin.

In October, I referred people to the NIH’s chart 2E, which placed ivermectin and nitazoxanide on the same footing as remdesivir in potential antiviral agents against COVID. At the time, I noted that while the NIH admitted in the chart that remdesivir (a big money-maker for hospitals) has the potential to cause kidney failure and liver toxicity, ivermectin and nitazoxanide were given the distinction of “generally well tolerated,” which is a term used to describe a near-perfect drug. I warned people to screenshot it (available on the Wayback Machine), lest the NIH remove or modify the page.

Well, it turns out that after many of us exposed the agency’s own position on ivermectin, it indeed removed the page, and instead, the URL takes you to an updated chart “2F” with changes. Updated on Dec. 16, the new chart specifically says that remdesivir is approved and the other two drugs are not. Additionally, it removes the status of “generally well tolerated” from ivermectin and nitazoxanide.

Here is a screenshot of the old 2E chart of side effects of ivermectin and nitazoxanide:

undefined
(bigger)

Now here is the updated version without the “generally well tolerated” status:

undefined
(Bigger)

Remember, the original chart was updated on July 8, 2021, well into the pandemic. Nothing has changed since July other than ivermectin becoming mainstream in public knowledge. The approval status was the same then as it is now, and there is zero evidence of more side effects. In fact, millions of doses have been administered without incident, and certainly much more safely than remdesivir. Even if one were to suggest that the NIH is dinging ivermectin based on its own lies and rumors about people getting sick from overdosing on the horse paste (because government has made it hard to get the human pills), how could officials possibly take the distinction away from nitazoxanide? It’s too rare and expensive for people to use, and there is little evidence people used it, much less had adverse reactions to this very safe drug.

Keep in mind that remdesivir is not even a fully approved FDA drug, while the other two have been approved for years with stellar safety profiles. The market category for remdesivir is still listed on the FDA National Drug Code Directory as “Unapproved Drug Other” and shows end marketing dates of 9/20/23 and 8/31/22. Both nitazoxanide and ivermectin, on the other hand, are categorized as FDA-approved drugs.

Indeed, it would be quite illuminating to get hold of FOIA documents of correspondence leading up to these changes.

Fair Use Excerpt. Read the whole article here.

from

via IFTTT

No comments:

Post a Comment

Merchandise

Ron Paul America Cloud

Site Credits

Ron Paul America

is voluntarily affiliated with

Liberty Operations Group

______________________________

Site created, maintained and hosted by

Liberty Web Services

Tags

#TurnOnTheTruth 2008 2012 4th amendment 911 ACTION Afghanistan war Agency Aggression Principle al-Qaeda Alan Colmes Alert America America's Fault Americans antigun AR 15 assault weapon Audit Authoritarian bailouts Believe Big Brother big government bill of rights Blame blowback bubbles Bush Campaign for Liberty Career Politician Eric Cantor Central Bank Charity China churches collapse Collectivism Commission committee Compassion Congress Conservative constitution Crash dangerous person Democrat Democrats Donald Trump Donald Trump. Planned Parenthood drones economic Economy Edward Snowden End the Fed European Union Federal Reserve Floyd Bayne floyd bayne for congress force foreign interventionism free market free markets GOP Nominee GOP Presidential Debates Government Great Depression gun control House of Representatives housing bubble HR 1745 I like Ron Paul except on foreign policy If ye love wealth better than liberty IFTTT Individual Individualism Institute Irag Iran Iraq war ISIL ISIS Judge Andrew Napalitano libertarian Liberty Liberty Letters Liberty Report Lost mass Media meltdown metadata Micheal Moore Middle East Mitt Romney nap National Neocons New Ron Paul Ad New York Times Newsletters Newt Gingrich No Non non-interventionism NSA NSA Snooping Obama Overreach overthrow Patriot Act peace Peace and Prosperity politicians Pope Francis President Presidential Presidential Race programs prosperity Race Racist Racist Newsletters Rand Paul Read the Bills Act recessions redistribution of wealth refugee crisis Repeal Obamacare Report Republican Republican Nomination Republican Nominee Republicans Revolution Rick Santorum Rick Santorum Exposed Ron Ron Paul Ron Paul Institute Ron Paul Institute Featured Articles Ron Paul Institute for Peace And Prosperity Ron Paul Institute Peace and Prosperity Articles Ron Paul Next Chapter Media Channel Ron Paul Racist Newsletters ron paul's foreign policy Ronald Reagan ronpaulchannel.com ronpaulinstitute.org Rosa DeLauro russia Samuel Adams Saudi Arabia Second Amendment Security Senate Senator September 11th attacks Show Soviet Spying stimulate Stock Market surveillance Syria tech bubble terrorist The the Fed the poor US US foreign policy Us troops USA Freedom Act Virginia Virginia Republican Primary voluntarism. Liberty Voluntary Warner Warning warrantless wiretaps YouTube